Skip to Main Content

A randomised, controlled, open label, multicentre, multinational, treat-to-target trial investigating the efficacy and safety of intensification with addition of bolus insulin aspart in subjects with type 2 diabetes inadequately controlled on basal insul

Principal Investigator

Bresta Miranda-Palma

Clinical Trial ID

Institutional Protocol # 20100753

Clinical Trial Summary


Phase

Phase IV


Funding Agency/Sponsor

Industry


Disease



Contact Information

Study Contact Burlett Masters
Phone Number 305-243-5354